Diabetes is Associated With Severe Adverse Events in Multidrug-Resistant Tuberculosis
Authors:
- Marcela Muñoz-TorricoMMMarcela Muñoz-Torrico
- José Caminero-LunaJCJosé Caminero-Luna
- Giovanni Battista MiglioriGMGiovanni Battista Migliori
- Lia D’aMbrosioLDLia D’aMbrosio
- José Luis Carrillo-AlduendaJCJosé Luis Carrillo-Alduenda
- Héctor Villareal-VelardeHVHéctor Villareal-Velarde
- Alfredo Torres-CruzATAlfredo Torres-Cruz
- Héctor Flores-VergaraHFHéctor Flores-Vergara
- Dina Martínez-MendozaDMDina Martínez-Mendoza
- Cecilia García-SanchoCGCecilia García-Sancho
- Rosella CentisRCRosella Centis
- Miguel Ángel Salazar-LezamaMSMiguel Ángel Salazar-Lezama
- 1 May 2017
- journal article
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 53 (5) , 245-250
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Efficacy and tolerability of ethionamideversusprothionamide: a systematic reviewEuropean Respiratory Journal, 2016
- Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatmentEuropean Respiratory Journal, 2015
- Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000–2012PLOS ONE, 2015
- Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenariosEuropean Respiratory Journal, 2014
- Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis.The International Journal of Tuberculosis and Lung Disease, 2013
- Scaling up interventions to achieve global tuberculosis control: progress and new developmentsThe Lancet, 2012
- Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysisEuropean Respiratory Journal, 2012
- European Union Standards for Tuberculosis CareEuropean Respiratory Journal, 2012
- Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosisThe Lancet Infectious Diseases, 2010
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational StudiesPLOS Medicine, 2008